KJKaustubh Jumle

Kaustubh Jumle

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kaustubh Jumle has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pollution-Induced Allergy Skews Metabolism Toward Obesity—A Conceptual Review

    by Kaustubh Jumle, Fehmi Boufahja, Anis Ahmad Chaudhary, Manali Datta

    Rapid urbanization and significant lifestyle changes have become the risk drivers for the epidemiology of diseases. With urban transitions, substantial persistence of pollutants in the environment has been observed. Epidemiological studies indicate a strong relationship between air pollution and exacerbation of asthma and other allergic diseases due to particulate matter (PM). PMs in bioaerosols and aeroallergens induce the immune response, eliciting systemic inflammation. Continuous exposure to PM2.5 along with gases like nitrogen oxide aggravate oxidative stress and inflammatory responses. Other pollutants elevate blood glucose, inducing poor sleep patterns which in turn induce low-grade chronic inflammation. This in turn acts as a trigger for adipocyte dysfunction and reduced energy expenditure. Taken together, air pollution, allergy, and obesity constitute a jigsaw with missing pieces. Transient Receptor Protein (TRP) channels have important roles in allergic rhinitis, systemic inflammation, adipogenesis, and obesity development, underscoring a potential role as a common mechanistic link. The goal of this review is to summarize and comprehend the intricate network connecting these “modern-day hyperendemic diseases” and the plausible role played by TRP in shaping their epidemiology. Bioactive compounds in dietary spices also modulate TRP channels. Thus, spices position themselves as potential regulators at the interface of environmental sensing, inflammation, and metabolism, indicating spice-based interventions may represent an adjunct strategy to alleviate the pollution-induced allergy and obesity risk.

  • Open Access

    Innovative Fatty Acid-Guided Biosensor Design for Neutrophil Gelatinase, a Prognostic and Diagnostic Biomarker for Chronic Kidney Disease

    by Kaustubh Jumle, Priya Paliwal, Mohamed A. M. Ali, Ravi Ranjan Kumar Niraj, Anis Ahmad Chaudhary, Manali Datta

    Chronic kidney disease (CKD) afflicts 850 million people worldwide, with an estimate that it is the 5th highest cause of years of life lost (YLLs). Standard confirmatory procedures for disease are blood and urine analysis with ultrasound for confirmation. Neutrophil gelatinase-associated lipocalin (NGAL) has been established as a prognostic biomarker, especially for the pre-clinical stages of CKD, thus presenting itself as a dependable predictor of the progression. With the aim of designing diagnostics, fatty acids were explored as potential biorecognition elements for the selective capture of NGAL. Three fatty acids—linoleic acid, arachidonic acid, and retinoic acid—were shortlisted as plausible candidates based on their known affinity toward lipocalin family proteins. Docking followed by molecular dynamics simulations were employed to evaluate the binding affinity and stability of each complex. Among them, linoleic acid exhibited the most favorable interaction, as evidenced by the lowest binding free energy. Subsequently, fluorescence and electrochemical techniques—square-wave voltammetry, differential pulse voltammetry, cyclic voltammetry, and electrochemical impedance spectroscopy (EIS)—were systematically compared for qualitative and quantitative checking of the accuracy of NGAL detection. Amongst the electrochemical techniques, differential pulse voltammetry DPV demonstrated superior analytical performance with an LOD of 0.05 ng/mL with a sensitivity of 23.2 µA/cm2/pg. To the best of our knowledge, this is the first report of a fatty acid-based biosensor platform for NGAL detection, presenting a novel approach for CKD diagnostics. The sensitivity obtained is comparable with available NGAL detection methods yet cost-effective and robust.

  • Open Access

    New approaches of green silver nanoparticles for cancer and biomedical applications: a review

    by Puja Kumari, Khushi Quadri, Renu Kadian, Saloni Mishra, Aafrin Waziri, Kaustub Jumle, Kumar Sambhav Verma, Sabir Alam

    The green synthesis of silver nanoparticles (AgNPs) has recently gained prominence as a sustainable and eco-friendly alternative to conventional physical and chemical methods. Utilizing biological entities such as plant extracts, bacteria, fungi, and biomolecules, the method acts by both reducing and stabilizing mechanisms. It does not use any harmful chemical substances, thus proving to be eco-friendly. Green-synthesized AgNPs exhibit enhanced biocompatibility, stability, and targeted delivery of the drug due to the use of naturally derived surface capping agents. These unique characteristics allow selective interference with cancer cells. The mechanism involved is the generation of reactive oxygen species (ROS), the induction of apoptosis, DNA damage, and cell cycle arrest. Green AgNPs also possess broad-spectrum antimicrobial, catalytic, antiparasitic, and anti-inflammatory properties, supporting the fact that they can be utilised in biomedical fields such as drug delivery, bioimaging, biosensing, tissue engineering, and regenerative medicine. Recent advancements have focused on controlling NP size, shape, and surface functionality to maximize efficacy while simultaneously minimizing cytotoxicity. This review provides a comprehensive analysis of the latest green synthesis strategies, their characterizations, and the molecular mechanisms by which they exert anticancer effects. Recent patents highlight the clinical potential of AgNPs in cancer therapy. US Patent 12201650 (2025) describes green synthesis using Caralluma sinaica, while other patents (WO2007001453, US7462753) outline adaptable biomedical formulations. Studies on biogenic AgNPs also show significant tumor inhibition and selective cytotoxicity against cancer cells. Furthermore, the article discusses current biomedical applications and critically evaluates the limitations, such as reproducibility, toxicity concerns, and scalability for clinical translation. Addressing these challenges is essential for the integration of green AgNPs into mainstream cancer therapeutics. The convergence of nanotechnology and biologically derived synthesis opens promising avenues for the development of safe, effective, and environmentally sustainable medical innovations.